(19)
(11) EP 3 169 660 A1

(12)

(43) Date of publication:
24.05.2017 Bulletin 2017/21

(21) Application number: 14748380.4

(22) Date of filing: 16.07.2014
(51) International Patent Classification (IPC): 
C07C 69/712(2006.01)
C07D 257/06(2006.01)
C07D 263/22(2006.01)
C07D 295/088(2006.01)
C07C 59/72(2006.01)
A61K 31/192(2006.01)
A61K 31/341(2006.01)
C07D 453/02(2006.01)
C07D 235/06(2006.01)
C07D 493/00(2006.01)
C07D 307/20(2006.01)
A61K 31/215(2006.01)
A61K 31/165(2006.01)
A61P 9/12(2006.01)
(86) International application number:
PCT/US2014/046920
(87) International publication number:
WO 2016/010538 (21.01.2016 Gazette 2016/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(71) Applicant: Corsair Pharma, Inc.
South San Francisco, California 94080 (US)

(72) Inventors:
  • BECKER, Cyrus K.
    Fremont, California 94538 (US)
  • RESCOURIO, Gwenaella
    San Mateo, California 94402 (US)
  • PFISTER, Jürg
    Los Altos, California 94024 (US)
  • VENKATRAMAN, Meenakshi
    Fremont, California 94555 (US)
  • ZHANG, Xiaoming
    Sunnyvale, California 94087 (US)

(74) Representative: Lahrtz, Fritz 
Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68
81675 München
81675 München (DE)

   


(54) TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME